Thursday, October 18, 2018

FOX BIZ NEWS: Novartis boosts outlook, announces $2.1B Endocyte deal


Novartis boosts outlook, announces $2.1B Endocyte deal



The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.

via FOX BUSINESS NEWS https://ift.tt/2yl71n6

No comments:

Post a Comment